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policies. We believe this information is valuable to local,
regional and national service commissioning groups in the
redirection of efforts and resources to target populations
where more urgent intervention is required. Points can be
learnt from the top performing regions to improve delivery
and establish uniformity of care. This project not only identi-
fies the need for continued work in this domain, but also pro-
vides a foundation and structure for further analysis of the
current services offered in secondary care.
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Background Multiple transfusion therapy in Thalassemia Major
has led to increased life expectancy but complications like
endocrine dysfunction can occur due to secondary iron depo-
sition especially in the endocrine organs despite chelation
therapy.
Objectives The objective of this study was to determine the
prevalence of endocrine dysfunctions in Transfusion dependent
Thalassemic patients and correlation between serum ferritin
levels and specific endocrine dysfunction.
Methods The study included Transfusion dependent Thalassemic
patients between the age group 5 to 18 years receiving at least a
year of chelation therapy with deferasirox in a tertiary care
centre. After proper consent/assent and clearance from the ethi-
cal committee, patients’ characteristics and investigations were
recorded on a predesigned proforma. Patients were analysed for
endocrine dysfunctions like Growth hormone deficiency, Hypo-
thyroidism, Parathyroid dysfunction, dysglycemia and delayed
puberty. Assessment for parathyroid dysfunction, dysglycemia
and puberty was done in patients more than 10 years of age
only.Data was expressed as Mean± S.D. with 95% confidence
Intervals. Correlation between endocrine dysfunctions and serum
ferritin levels was investigated using Pearson’s correlation and p
value of <0.05 was considered significant.
Results A total of 50 patients completed the study, out of
which 16 patients were more than 10 years of age. The mean
age of the study participants was 8.3±2.70 years with a male
to female ratio of 2.8:1. The mean age of diagnosis was
16.87±14.03months and mean duration of chelation was
38.40±26.71 months. Endocrine dysfunction was observed in
28 patients (56%). Evaluation for parathyroid dysfunction,
dysglycemia and pubertal disorders was done in patients more
than 10 years of age only while short stature and thyroid dys-
function was evaluated in all 50 patients completing the study.
Maximum prevalence was of parathyroid dysfunction,
observed in 10 patients (62.5%) followed by short stature in
17 patients (34%), Impaired Fasting Glucose/Impaired Glucose
Tolerance in 4 patients (25%) and subclinical hypothyroidism
in 7 patients (14%). Pubertal delay and overt diabetes were
not detected in any of the patients. Growth hormone defi-
ciency on provocative stimulation test was observed in 8
patients out of 17 patients (47.05%) with short stature. The
serum ferritin levels did not show a significant correlation
with any of the endocrine dysfunctions.
Conclusions This study showed that 56% of the Transfusion
dependent Thalassemics had at least one endocrinopathy. A
statistically insignificant correlation of endocrinopathy with
serum ferritin levels was observed in the study. Irrespective of
chelation therapy, patients with transfusion dependent thalasse-
mia can have a considerably high prevalence of endocrine
complications. Serum levels of ferritin cannot be utilised as a
predictor of endocrine dysfunctions. Therefore, all patients
with Thalassemia requiring frequent transfusions should
undergo regular monitoring for endocrinopathies.
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Background Peri-conceptional folic acid (FA) supplementation
is known to prevent neural tube defects. It remains uncertain
whether continuing FA after the first trimester has benefits for
offspring neurodevelopment. A previously published follow up
study of Mothers who had participated in a randomized trial
of FA Supplementation in the Second and Third Trimesters
(FASSTT) in pregnancy and who had received 400 micro-
grams/day FA or placebo from the 14th gestational week until
the end of pregnancy showed their offspring at both 3 and 7
years scored significantly higher than the placebo group in
word reasoning and cognition.
Objectives Follow up investigation of 11 year old children,
whose Mothers had participated in a randomized trial of FA
Supplementation in the Second and Third Trimesters (FASSTT)
in pregnancy and received 400 micrograms/day FA or placebo
from the 14th gestational week to determine if previous
improvement in Cognitive performance and brain function
persists in this age group.
Methods Mother - child pairs who undertook the FASSTT
trial (healthy pregnant women aged 18–35 years with single-
ton pregnancy) and who had taken 400 micrograms/day of FA
in the first trimester were randomized to receive FA supple-
ments or placebo until the end of pregnancy. When the child
was 11 years old Mother-child pairs were recruited by invita-
tion to undergo assessment of the child`s Cognitive perform-
ance by the Wechsler Intelligence Scale for Children (WISC-
IV). Assessors were blinded to the treatment allocation of the
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Mother during the FASSTT trial. In a sub sample of partici-
pants, magnetoencephalographic(MEG)brain imaging was per-
formed to assess brain functioning through estimating
neuronal activity in relation to semantic processing of lan-
guage. Related covariates including general health and lifestyle
measures, socioeconomic status, anthropometry including BMI
status, B-vitamin biomarkers and nutritional dietary analysis
were evaluated. Statistical analysis was performed using the
Statistical package for the Social Services software.
Results Of the 119 mother-child pairs in the FASSTT trial, 68
children were assessed for neurocognitive performance at 11-
year follow up (Dec 2017 to Nov 2018). Children of mothers
randomized to FA compared with placebo scored significantly
higher in two Processing Speed tests i.e. symbol search (mean
difference 2.9 points, 95% CI 0.3 to 5.5,p=0.03) and cancel-
lation (11.3 points,2.5 to 20.1, p=0.04), whereas the positive
effect on Verbal Comprehension was significant in girls only
(6.5 points, 1.2 to 11.8, p=0.03).
MEG assessment of neuronal responses to a language task
showed increased power at the Beta (13–30 Hz, p=0.01) and
High Gamma (49–70 Hz, P=0.04) bands in children from
FA-supplemented mothers, suggesting more efficient semantic
processing of language.
Conclusions Continued FA supplementation in pregnancy
beyond the early period currently recommended to prevent
NTD, can benefit neurocognitive development of the child.
MEG provides a non-invasive tool in paediatric research to
objectively assess functional brain activity in response to nutri-
tion and other interventions. Our findings add considerably to
the existing evidence that have linked maternal folate status in
pregnancy with neurocognitive outcomes in the older child.
This evidence reinforces our previous findings in these chil-
dren and suggest that continued FA intervention in pregnancy
beyond the early period is beneficial to future neurocognitive
development.
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Background Storytelling is a powerful tool in education where
emotional investment rewards enhanced learning.We designed
a ‘choose your own adventure’ story written in the second
person where the participant assumes the role of a junior doc-
tor taking decisions in the resuscitation of an infant. The deci-
sions taken influence both the narrative and learner’s role
making it truly interactive. This breaks from traditional e-
learning techniques with linear progression. Instead the learner
is supported in a safe environment to make realistic clinical
decisions. The purpose of such engagement is to stimulates
interest, simulate real clinical practice and enables higher level
learning whilst also testing knowledge in a way that allows
detailed personal feedback.
In the current climate of the COVID-19 pandemic, the aim
was to produce an innovative e-module that engaged and
entertained learners who most likely will have a degree of
online burnout. Learning objectives are taken from the
advanced paediatric life support course. Retention of knowl-
edge is paramount and through simulating auditory, visual and
cognitive cues it is hoped translation into practice is
improved.
Objectives In this study, we had the following two aims.
Firstly to gather user feedback to determine areas for
improvement with subsequent versions. Secondly, to determine
the utility of digital simulation in healthcare education as a
tool to impact clinical practice.
Methods Many approaches to evaluation exist. Using a frame-
work described by Roland et al. we crafted a pre and post-
questionnaire to assess more than simply user experience.
Users including all clinical staff in our tertiary hospital emer-
gency department via email. Hence sampling was not random
and instead was opportunistic. Beforehand, an anonymous
online survey firstly gathered demographic data about users
(for example; age, sex, ethnicity, profession group and training
experience).
Afterwards, a series of questions were asked, again via an
anonymous online survey, to determine the utility of the digi-
tal simulation with regards to the following; interactivity,
interface, instruction, ideation (what you think you have
learned), integration (what you have shown you have learned),
implementation and improvement. This 7Is framework allows
potential patient benefit to encapsulated in its outcome meas-
ures as has an existing precedent for use as demonstrated in a
previous study examining outcomes of a separate e-learning
package.
Results Results include the following; 90% had high motiva-
tion, 60% were able to easily access the module (desktop
computer, smartphone etc), 100% wished to utilise the same
style of learning again, 80% report gaining new knowledge or
skills, mean time to complete module was 22 minutes, blank
space feedback included; ‘novel and engaging format, unclear
at first how to select choices,’ ‘needs to include feedback at
each decision point, not at end,’ ‘learnt airway skills and steps
to expect in the resuscitation of a baby.’ The first one hun-
dred staff to respond were included in this data set with
good representation across the different demographic groups.
Conclusions This work represents preliminary stages of devel-
opment for a novel elearning module.Results suggest with fur-
ther improvement this is a format that has the potential to
engage, educate and impact upon clinical practice.
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